Hence, in this study, we aimed to explore whether RAC can attenuate RCC by modulation of inflammation, oxidative stress, apoptosis, proliferation, and autophagy via the PI3K/AKT/mTOR and MAPK pathway, thus providing a novel strategy for treating RCC. The gene discussed is MTOR; the disease is renal cell carcinoma.